Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO15124 | Herba sedi sarmentosi | NA | NA | NA | TCMID* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT5625 | Individual Protein | 3-beta-hydroxysteroid-delta(8),delta(7)-isomerase | Cavia porcellus | Ki | = | 2.71 | nM | 12747784 |
NPT1496 | Protein Complex | Glutamate NMDA receptor | Rattus norvegicus | IC50 | = | 263 | nM | 1681106 |
NPT968 | Protein Family | Adrenergic receptor alpha-1 | Rattus norvegicus | IC50 | = | 100 | nM | 1681106 |
NPT5856 | Individual Protein | Serotonin 2a (5-HT2a) receptor | Bos taurus | IC50 | = | 610 | nM | 1681106 |
NPT5255 | Individual Protein | Serotonin 1a (5-HT1a) receptor | Mus musculus | IC50 | = | 238 | nM | 1681106 |
NPT968 | Protein Family | Adrenergic receptor alpha-1 | Rattus norvegicus | IC50 | = | 110 | nM | 1681106 |
NPT145 | Individual Protein | Mu opioid receptor | Homo sapiens | IC50 | > | 1000 | nM | 1681106 |
NPT296 | Individual Protein | Sigma opioid receptor | Homo sapiens | IC50 | = | 3.9 | nM | 1681106 |
NPT251 | Individual Protein | Histamine H1 receptor | Homo sapiens | IC50 | = | 1000 | nM | 1681106 |
NPT5857 | Individual Protein | Dopamine D1 receptor | Mus musculus | IC50 | > | 1000 | nM | 1681106 |
NPT243 | Individual Protein | Dopamine D2 receptor | Homo sapiens | IC50 | > | 1000 | nM | 1681106 |
NPT1303 | Individual Protein | Muscarinic acetylcholine receptor M3 | Rattus norvegicus | IC50 | > | 1000 | nM | 1681106 |
NPT1067 | Individual Protein | Sigma opioid receptor | Rattus norvegicus | Ki | = | 4.9 | nM | 10602703 |
NPT5625 | Individual Protein | 3-beta-hydroxysteroid-delta(8),delta(7)-isomerase | Cavia porcellus | Ki | = | 4.7 | nM | 16366605 |
NPT5625 | Individual Protein | 3-beta-hydroxysteroid-delta(8),delta(7)-isomerase | Cavia porcellus | Ki | = | 19.8 | nM | 17713896 |
NPT3933 | Individual Protein | Glutamate [NMDA] receptor subunit epsilon 2 | Rattus norvegicus | Ki | = | 11 | nM | 18434149 |
NPT3933 | Individual Protein | Glutamate [NMDA] receptor subunit epsilon 2 | Rattus norvegicus | Ratio | = | 1 | 18434149 | |
NPT3930 | Protein Complex | Glutamate NMDA receptor; GRIN1/GRIN2B | Homo sapiens | IC50 | = | 110 | nM | 18434149 |
NPT3930 | Protein Complex | Glutamate NMDA receptor; GRIN1/GRIN2B | Homo sapiens | Ratio IC50 | = | 1 | 18434149 | |
NPT1163 | Individual Protein | Glutamate (NMDA) receptor subunit zeta 1 | Rattus norvegicus | IC50 | = | 73 | nM | 18800760 |
NPT1070 | Individual Protein | Sigma-1 receptor | Cavia porcellus | Ki | = | 2 | nM | 19053780 |
NPT2 | Others | Unspecified | Ki | = | 2.3 | nM | 19053780 | |
NPT306 | Cell Line | PC-3 | Homo sapiens | Ki | = | 25.8 | nM | 19053780 |
NPT2 | Others | Unspecified | Ratio Ki | = | 0.12 | 19053780 | ||
NPT2 | Others | Unspecified | Ratio Ki | = | 0.14 | 19053780 | ||
NPT306 | Cell Line | PC-3 | Homo sapiens | Activity | < | 10 | % | 19053780 |
NPT5625 | Individual Protein | 3-beta-hydroxysteroid-delta(8),delta(7)-isomerase | Cavia porcellus | Ki | = | 16.4 | nM | 19053780 |
NPT3933 | Individual Protein | Glutamate [NMDA] receptor subunit epsilon 2 | Rattus norvegicus | IC50 | = | 20.5 | nM | 19157884 |
NPT1067 | Individual Protein | Sigma opioid receptor | Rattus norvegicus | Ki | = | 2 | nM | 19673530 |
NPT5625 | Individual Protein | 3-beta-hydroxysteroid-delta(8),delta(7)-isomerase | Cavia porcellus | Ki | = | 10.2 | nM | 19842660 |
NPT3930 | Protein Complex | Glutamate NMDA receptor; GRIN1/GRIN2B | Homo sapiens | Ratio | = | 0.06 | 20692832 | |
NPT2 | Others | Unspecified | Ratio | = | 0.87 | 20692832 | ||
NPT3929 | Protein Complex | Glutamate NMDA receptor; GRIN1/GRIN2A | Homo sapiens | Ratio | = | 0.77 | 20692832 | |
NPT3930 | Protein Complex | Glutamate NMDA receptor; GRIN1/GRIN2B | Homo sapiens | Inhibition | = | 0.94 | % | 20692832 |
NPT3930 | Protein Complex | Glutamate NMDA receptor; GRIN1/GRIN2B | Homo sapiens | IC50 | = | 190 | nM | 20692832 |
NPT2 | Others | Unspecified | Activity | = | 63 | % | 17417631 | |
NPT2 | Others | Unspecified | EC50 | = | 206 | nM | 17417631 | |
NPT2 | Others | Unspecified | EC50 | = | 420 | nM | 17417631 | |
NPT2 | Others | Unspecified | EC50 | = | 1990 | nM | 17417631 | |
NPT3933 | Individual Protein | Glutamate [NMDA] receptor subunit epsilon 2 | Rattus norvegicus | Ki | = | 20 | nM | 20875744 |
NPT3930 | Protein Complex | Glutamate NMDA receptor; GRIN1/GRIN2B | Homo sapiens | Ki | = | 10 | nM | 20965739 |
NPT1070 | Individual Protein | Sigma-1 receptor | Cavia porcellus | Ki | = | 125 | nM | 20965739 |
NPT2 | Others | Unspecified | Ki | = | 98.3 | nM | 20965739 | |
NPT483 | Individual Protein | Prelamin-A/C | Homo sapiens | Potency | = | 35481.3 | nM | PubChem BioAssay data set |
NPT312 | Organism | Saccharomyces cerevisiae | Saccharomyces cerevisiae | Potency | = | 16360.1 | nM | PubChem BioAssay data set |
NPT537 | Individual Protein | Ras-related protein Rab-9A | Homo sapiens | Potency | = | 58047.9 | nM | PubChem BioAssay data set |
NPT940 | Individual Protein | Serine/threonine-protein kinase mTOR | Homo sapiens | Potency | = | 10399.2 | nM | PubChem BioAssay data set |
NPT940 | Individual Protein | Serine/threonine-protein kinase mTOR | Homo sapiens | Potency | = | 11668.1 | nM | PubChem BioAssay data set |
NPT98 | Individual Protein | HERG | Homo sapiens | IC50 | = | 100 | nM | 21185626 |
NPT61 | Individual Protein | Beta-glucocerebrosidase | Homo sapiens | Potency | 35481.3 | nM | PubChem BioAssay data set | |
NPT64 | Individual Protein | ATPase family AAA domain-containing protein 5 | Homo sapiens | Potency | 12990 | nM | PubChem BioAssay data set | |
NPT242 | Individual Protein | Dopamine D1 receptor | Homo sapiens | Potency | 281.8 | nM | PubChem BioAssay data set | |
NPT242 | Individual Protein | Dopamine D1 receptor | Homo sapiens | Potency | 326.4 | nM | PubChem BioAssay data set | |
NPT5 | Individual Protein | Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 | Homo sapiens | Potency | 631 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 29092.9 | nM | PubChem BioAssay data set | ||
NPT64 | Individual Protein | ATPase family AAA domain-containing protein 5 | Homo sapiens | Potency | 18348.9 | nM | PubChem BioAssay data set | |
NPT242 | Individual Protein | Dopamine D1 receptor | Homo sapiens | Potency | 11220.2 | nM | PubChem BioAssay data set | |
NPT3930 | Protein Complex | Glutamate NMDA receptor; GRIN1/GRIN2B | Homo sapiens | IC50 | = | 177.4 | nM | 21453995 |
NPT3929 | Protein Complex | Glutamate NMDA receptor; GRIN1/GRIN2A | Homo sapiens | Inhibition | = | 22.27 | % | 21453995 |
NPT3930 | Protein Complex | Glutamate NMDA receptor; GRIN1/GRIN2B | Homo sapiens | IC50 | = | 340 | nM | 21453995 |
NPT3930 | Protein Complex | Glutamate NMDA receptor; GRIN1/GRIN2B | Homo sapiens | IC50 | = | 66 | nM | 21453995 |
NPT478 | Individual Protein | Ataxin-2 | Homo sapiens | Potency | 28183.8 | nM | PubChem BioAssay data set | |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | 19011.5 | nM | PubChem BioAssay data set | |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | 2133.1 | nM | PubChem BioAssay data set | |
NPT71 | Cell Line | HEK293 | Homo sapiens | Potency | 23099.9 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 20587.8 | nM | PubChem BioAssay data set | ||
NPT519 | Cell Line | SH-SY5Y | Homo sapiens | Potency | 31622.8 | nM | PubChem BioAssay data set | |
NPT5625 | Individual Protein | 3-beta-hydroxysteroid-delta(8),delta(7)-isomerase | Cavia porcellus | Ki | = | 15 | nM | 22075234 |
NPT445 | Individual Protein | Peripheral myelin protein 22 | Rattus norvegicus | Potency | 25574.8 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 36125.4 | nM | PubChem BioAssay data set | ||
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | 37585.7 | nM | PubChem BioAssay data set | |
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | 29855.4 | nM | PubChem BioAssay data set | |
NPT478 | Individual Protein | Ataxin-2 | Homo sapiens | Potency | 31622.8 | nM | PubChem BioAssay data set | |
NPT5858 | Individual Protein | Glutamate [NMDA] receptor subunit epsilon 2 | Mus musculus | Activity | = | 79 | % | 23140383 |
NPT5858 | Individual Protein | Glutamate [NMDA] receptor subunit epsilon 2 | Mus musculus | Activity | = | 153 | % | 23140383 |
NPT3933 | Individual Protein | Glutamate [NMDA] receptor subunit epsilon 2 | Rattus norvegicus | IC50 | = | 20 | nM | 23140383 |
NPT519 | Cell Line | SH-SY5Y | Homo sapiens | IC50 | = | 0.73 | nM | 23033965 |
NPT3933 | Individual Protein | Glutamate [NMDA] receptor subunit epsilon 2 | Rattus norvegicus | Ki | = | 29 | nM | 23033965 |
NPT2 | Others | Unspecified | Ki | = | 3080 | nM | 23033965 | |
NPT2 | Others | Unspecified | Ratio IC50 | = | 200 | 23458846 | ||
NPT2 | Others | Unspecified | IC50 | = | 3500 | nM | 23458846 | |
NPT3930 | Protein Complex | Glutamate NMDA receptor; GRIN1/GRIN2B | Homo sapiens | IC50 | = | 340 | nM | 23458846 |
NPT2 | Others | Unspecified | Potency | 21136 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 8414.4 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Ratio Ki | = | 0.05 | 24290063 | ||
NPT2 | Others | Unspecified | Ki | = | 18.8 | nM | 24290063 | |
NPT1070 | Individual Protein | Sigma-1 receptor | Cavia porcellus | Ki | = | 1.02 | nM | 24290063 |
NPT3933 | Individual Protein | Glutamate [NMDA] receptor subunit epsilon 2 | Rattus norvegicus | Ki | = | 19 | nM | 24290063 |
NPT3933 | Individual Protein | Glutamate [NMDA] receptor subunit epsilon 2 | Rattus norvegicus | IC50 | = | 20 | nM | 24411196 |
NPT5859 | Individual Protein | Glutamate [NMDA] receptor subunit epsilon 2 | Homo sapiens | IC50 | = | 20 | nM | 24411196 |
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | 33491.5 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 5353.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 21131.7 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 13333.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 31210 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 33491.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 23710.1 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 334.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 11220.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 2113.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 10000 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 237.1 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 668.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 2818.4 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 35481.3 | nM | PubChem BioAssay data set | ||
NPT1070 | Individual Protein | Sigma-1 receptor | Cavia porcellus | Ki | = | 125 | nM | 25458498 |
NPT5859 | Individual Protein | Glutamate [NMDA] receptor subunit epsilon 2 | Homo sapiens | Ki | = | 10 | nM | 25458498 |
NPT2 | Others | Unspecified | Ki | = | 98.3 | nM | 25458498 | |
NPT2 | Others | Unspecified | AC50 | 39810.7 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | AC50 | 17782.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | AC50 | 28183.8 | nM | PubChem BioAssay data set | ||
NPT3933 | Individual Protein | Glutamate [NMDA] receptor subunit epsilon 2 | Rattus norvegicus | IC50 | = | 47 | nM | 26912202 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC307020 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.8547 | High Similarity | NPC65855 |
0.8547 | High Similarity | NPC292758 |
0.843 | Intermediate Similarity | NPC213 |
0.843 | Intermediate Similarity | NPC10286 |
0.8168 | Intermediate Similarity | NPC89769 |
0.8168 | Intermediate Similarity | NPC126859 |
0.8168 | Intermediate Similarity | NPC259665 |
0.8154 | Intermediate Similarity | NPC268763 |
0.8154 | Intermediate Similarity | NPC66177 |
0.8154 | Intermediate Similarity | NPC8305 |
0.8083 | Intermediate Similarity | NPC290566 |
0.8083 | Intermediate Similarity | NPC145638 |
0.8065 | Intermediate Similarity | NPC82963 |
0.8017 | Intermediate Similarity | NPC289381 |
0.8017 | Intermediate Similarity | NPC214200 |
0.8017 | Intermediate Similarity | NPC228400 |
0.8017 | Intermediate Similarity | NPC155847 |
0.8 | Intermediate Similarity | NPC38458 |
0.8 | Intermediate Similarity | NPC311737 |
0.797 | Intermediate Similarity | NPC257390 |
0.7955 | Intermediate Similarity | NPC124802 |
0.7931 | Intermediate Similarity | NPC216468 |
0.7931 | Intermediate Similarity | NPC78119 |
0.7931 | Intermediate Similarity | NPC51333 |
0.7931 | Intermediate Similarity | NPC132078 |
0.7923 | Intermediate Similarity | NPC95733 |
0.7923 | Intermediate Similarity | NPC62101 |
0.7903 | Intermediate Similarity | NPC118202 |
0.7869 | Intermediate Similarity | NPC474149 |
0.7863 | Intermediate Similarity | NPC29477 |
0.7863 | Intermediate Similarity | NPC213730 |
0.7851 | Intermediate Similarity | NPC24101 |
0.7851 | Intermediate Similarity | NPC96224 |
0.784 | Intermediate Similarity | NPC317254 |
0.7829 | Intermediate Similarity | NPC474862 |
0.7812 | Intermediate Similarity | NPC321133 |
0.7797 | Intermediate Similarity | NPC7686 |
0.7797 | Intermediate Similarity | NPC40258 |
0.7797 | Intermediate Similarity | NPC91461 |
0.7759 | Intermediate Similarity | NPC473388 |
0.775 | Intermediate Similarity | NPC154899 |
0.775 | Intermediate Similarity | NPC233396 |
0.7742 | Intermediate Similarity | NPC290353 |
0.7742 | Intermediate Similarity | NPC42911 |
0.7742 | Intermediate Similarity | NPC153795 |
0.7717 | Intermediate Similarity | NPC137096 |
0.771 | Intermediate Similarity | NPC211218 |
0.7705 | Intermediate Similarity | NPC153690 |
0.7698 | Intermediate Similarity | NPC150712 |
0.7686 | Intermediate Similarity | NPC92623 |
0.7686 | Intermediate Similarity | NPC231705 |
0.7686 | Intermediate Similarity | NPC135464 |
0.7672 | Intermediate Similarity | NPC26244 |
0.7672 | Intermediate Similarity | NPC313650 |
0.7669 | Intermediate Similarity | NPC322366 |
0.7669 | Intermediate Similarity | NPC323775 |
0.7669 | Intermediate Similarity | NPC305717 |
0.7669 | Intermediate Similarity | NPC236347 |
0.7647 | Intermediate Similarity | NPC149379 |
0.7643 | Intermediate Similarity | NPC168861 |
0.7642 | Intermediate Similarity | NPC265211 |
0.7642 | Intermediate Similarity | NPC306045 |
0.7642 | Intermediate Similarity | NPC258056 |
0.7626 | Intermediate Similarity | NPC193528 |
0.7623 | Intermediate Similarity | NPC142297 |
0.7597 | Intermediate Similarity | NPC283760 |
0.7586 | Intermediate Similarity | NPC151715 |
0.7583 | Intermediate Similarity | NPC178902 |
0.7581 | Intermediate Similarity | NPC475018 |
0.7576 | Intermediate Similarity | NPC285394 |
0.7571 | Intermediate Similarity | NPC476989 |
0.7569 | Intermediate Similarity | NPC245974 |
0.7563 | Intermediate Similarity | NPC294741 |
0.7554 | Intermediate Similarity | NPC473055 |
0.7554 | Intermediate Similarity | NPC473052 |
0.754 | Intermediate Similarity | NPC123175 |
0.754 | Intermediate Similarity | NPC176730 |
0.7537 | Intermediate Similarity | NPC218323 |
0.7536 | Intermediate Similarity | NPC473360 |
0.7521 | Intermediate Similarity | NPC304761 |
0.7521 | Intermediate Similarity | NPC226778 |
0.7521 | Intermediate Similarity | NPC150254 |
0.7521 | Intermediate Similarity | NPC147000 |
0.7519 | Intermediate Similarity | NPC171372 |
0.7518 | Intermediate Similarity | NPC208757 |
0.7518 | Intermediate Similarity | NPC189724 |
0.7518 | Intermediate Similarity | NPC212850 |
0.7518 | Intermediate Similarity | NPC83289 |
0.7518 | Intermediate Similarity | NPC251439 |
0.7517 | Intermediate Similarity | NPC473491 |
0.75 | Intermediate Similarity | NPC138117 |
0.75 | Intermediate Similarity | NPC325292 |
0.75 | Intermediate Similarity | NPC301651 |
0.75 | Intermediate Similarity | NPC185838 |
0.75 | Intermediate Similarity | NPC473556 |
0.75 | Intermediate Similarity | NPC322526 |
0.748 | Intermediate Similarity | NPC120280 |
0.748 | Intermediate Similarity | NPC12656 |
0.7462 | Intermediate Similarity | NPC43275 |
0.7459 | Intermediate Similarity | NPC211551 |
0.7458 | Intermediate Similarity | NPC132271 |
0.7458 | Intermediate Similarity | NPC292730 |
0.7458 | Intermediate Similarity | NPC216520 |
0.7458 | Intermediate Similarity | NPC82664 |
0.7451 | Intermediate Similarity | NPC107938 |
0.7451 | Intermediate Similarity | NPC294516 |
0.7447 | Intermediate Similarity | NPC219233 |
0.7447 | Intermediate Similarity | NPC170170 |
0.7447 | Intermediate Similarity | NPC211468 |
0.7442 | Intermediate Similarity | NPC476266 |
0.744 | Intermediate Similarity | NPC63345 |
0.7431 | Intermediate Similarity | NPC247298 |
0.7419 | Intermediate Similarity | NPC262365 |
0.7414 | Intermediate Similarity | NPC45040 |
0.7413 | Intermediate Similarity | NPC266741 |
0.7405 | Intermediate Similarity | NPC115627 |
0.7405 | Intermediate Similarity | NPC118522 |
0.7405 | Intermediate Similarity | NPC169207 |
0.7403 | Intermediate Similarity | NPC169743 |
0.7397 | Intermediate Similarity | NPC476151 |
0.7397 | Intermediate Similarity | NPC179825 |
0.7397 | Intermediate Similarity | NPC321505 |
0.7397 | Intermediate Similarity | NPC191376 |
0.7394 | Intermediate Similarity | NPC323123 |
0.7377 | Intermediate Similarity | NPC323810 |
0.7376 | Intermediate Similarity | NPC14600 |
0.7376 | Intermediate Similarity | NPC214988 |
0.7376 | Intermediate Similarity | NPC160607 |
0.7376 | Intermediate Similarity | NPC204848 |
0.7376 | Intermediate Similarity | NPC41473 |
0.7376 | Intermediate Similarity | NPC312770 |
0.7361 | Intermediate Similarity | NPC81026 |
0.736 | Intermediate Similarity | NPC62258 |
0.736 | Intermediate Similarity | NPC55617 |
0.7357 | Intermediate Similarity | NPC64205 |
0.7355 | Intermediate Similarity | NPC327226 |
0.7353 | Intermediate Similarity | NPC296712 |
0.7348 | Intermediate Similarity | NPC56634 |
0.7347 | Intermediate Similarity | NPC147390 |
0.7347 | Intermediate Similarity | NPC135538 |
0.7347 | Intermediate Similarity | NPC24233 |
0.7347 | Intermediate Similarity | NPC476571 |
0.7347 | Intermediate Similarity | NPC428 |
0.7347 | Intermediate Similarity | NPC246587 |
0.7344 | Intermediate Similarity | NPC473137 |
0.7338 | Intermediate Similarity | NPC325568 |
0.7333 | Intermediate Similarity | NPC128723 |
0.7333 | Intermediate Similarity | NPC92730 |
0.7333 | Intermediate Similarity | NPC125732 |
0.7328 | Intermediate Similarity | NPC300017 |
0.7328 | Intermediate Similarity | NPC300478 |
0.7328 | Intermediate Similarity | NPC268572 |
0.7325 | Intermediate Similarity | NPC476227 |
0.7324 | Intermediate Similarity | NPC197921 |
0.7323 | Intermediate Similarity | NPC228425 |
0.7319 | Intermediate Similarity | NPC326966 |
0.7319 | Intermediate Similarity | NPC45191 |
0.7317 | Intermediate Similarity | NPC474839 |
0.731 | Intermediate Similarity | NPC16188 |
0.7308 | Intermediate Similarity | NPC283468 |
0.7308 | Intermediate Similarity | NPC150879 |
0.7308 | Intermediate Similarity | NPC230611 |
0.7302 | Intermediate Similarity | NPC321252 |
0.7302 | Intermediate Similarity | NPC120982 |
0.7302 | Intermediate Similarity | NPC79793 |
0.7302 | Intermediate Similarity | NPC147634 |
0.7302 | Intermediate Similarity | NPC252544 |
0.7302 | Intermediate Similarity | NPC174096 |
0.7302 | Intermediate Similarity | NPC44732 |
0.7302 | Intermediate Similarity | NPC226401 |
0.7297 | Intermediate Similarity | NPC103379 |
0.7297 | Intermediate Similarity | NPC477565 |
0.7293 | Intermediate Similarity | NPC469686 |
0.729 | Intermediate Similarity | NPC134858 |
0.7288 | Intermediate Similarity | NPC128062 |
0.7285 | Intermediate Similarity | NPC244336 |
0.728 | Intermediate Similarity | NPC11554 |
0.728 | Intermediate Similarity | NPC61885 |
0.728 | Intermediate Similarity | NPC63698 |
0.7279 | Intermediate Similarity | NPC476353 |
0.7273 | Intermediate Similarity | NPC91953 |
0.7273 | Intermediate Similarity | NPC469360 |
0.7273 | Intermediate Similarity | NPC263835 |
0.7266 | Intermediate Similarity | NPC244866 |
0.7266 | Intermediate Similarity | NPC328070 |
0.7266 | Intermediate Similarity | NPC118419 |
0.7261 | Intermediate Similarity | NPC273755 |
0.7261 | Intermediate Similarity | NPC306804 |
0.7258 | Intermediate Similarity | NPC113457 |
0.7258 | Intermediate Similarity | NPC271274 |
0.7255 | Intermediate Similarity | NPC59028 |
0.7255 | Intermediate Similarity | NPC92191 |
0.7254 | Intermediate Similarity | NPC471201 |
0.7252 | Intermediate Similarity | NPC122009 |
0.7252 | Intermediate Similarity | NPC469609 |
0.7252 | Intermediate Similarity | NPC471671 |
0.725 | Intermediate Similarity | NPC226096 |
0.725 | Intermediate Similarity | NPC164514 |
0.725 | Intermediate Similarity | NPC474073 |
0.725 | Intermediate Similarity | NPC225464 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC307020 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
1.0 | High Similarity | NPD4659 | Approved |
0.9664 | High Similarity | NPD4103 | Phase 2 |
0.9664 | High Similarity | NPD4104 | Clinical (unspecified phase) |
0.9487 | High Similarity | NPD5238 | Clinical (unspecified phase) |
0.9091 | High Similarity | NPD2562 | Approved |
0.9091 | High Similarity | NPD2561 | Approved |
0.8595 | High Similarity | NPD317 | Approved |
0.8595 | High Similarity | NPD16 | Approved |
0.8595 | High Similarity | NPD318 | Approved |
0.8595 | High Similarity | NPD856 | Approved |
0.8548 | High Similarity | NPD5351 | Clinical (unspecified phase) |
0.8548 | High Similarity | NPD5350 | Clinical (unspecified phase) |
0.8417 | Intermediate Similarity | NPD2234 | Approved |
0.8417 | Intermediate Similarity | NPD2228 | Approved |
0.8417 | Intermediate Similarity | NPD2229 | Approved |
0.8376 | Intermediate Similarity | NPD4095 | Clinical (unspecified phase) |
0.8374 | Intermediate Similarity | NPD5304 | Approved |
0.8374 | Intermediate Similarity | NPD5303 | Approved |
0.8346 | Intermediate Similarity | NPD3553 | Approved |
0.8346 | Intermediate Similarity | NPD3554 | Approved |
0.8346 | Intermediate Similarity | NPD3555 | Approved |
0.8346 | Intermediate Similarity | NPD3552 | Approved |
0.8306 | Intermediate Similarity | NPD4093 | Discontinued |
0.8281 | Intermediate Similarity | NPD1133 | Approved |
0.8281 | Intermediate Similarity | NPD1131 | Approved |
0.8281 | Intermediate Similarity | NPD1134 | Approved |
0.8281 | Intermediate Similarity | NPD1135 | Approved |
0.8281 | Intermediate Similarity | NPD1129 | Approved |
0.8271 | Intermediate Similarity | NPD3054 | Approved |
0.8271 | Intermediate Similarity | NPD3052 | Approved |
0.8271 | Intermediate Similarity | NPD2568 | Approved |
0.8182 | Intermediate Similarity | NPD6405 | Approved |
0.8182 | Intermediate Similarity | NPD6407 | Approved |
0.8168 | Intermediate Similarity | NPD5156 | Approved |
0.8168 | Intermediate Similarity | NPD5155 | Approved |
0.8167 | Intermediate Similarity | NPD4025 | Clinical (unspecified phase) |
0.8154 | Intermediate Similarity | NPD3635 | Approved |
0.8154 | Intermediate Similarity | NPD3636 | Approved |
0.8154 | Intermediate Similarity | NPD3637 | Approved |
0.8134 | Intermediate Similarity | NPD823 | Approved |
0.8134 | Intermediate Similarity | NPD817 | Approved |
0.8103 | Intermediate Similarity | NPD854 | Approved |
0.8103 | Intermediate Similarity | NPD855 | Approved |
0.8092 | Intermediate Similarity | NPD2605 | Approved |
0.8092 | Intermediate Similarity | NPD2606 | Approved |
0.8083 | Intermediate Similarity | NPD9380 | Clinical (unspecified phase) |
0.8065 | Intermediate Similarity | NPD6775 | Clinical (unspecified phase) |
0.8029 | Intermediate Similarity | NPD4721 | Approved |
0.8029 | Intermediate Similarity | NPD4726 | Approved |
0.8029 | Intermediate Similarity | NPD4725 | Approved |
0.8015 | Intermediate Similarity | NPD1753 | Discontinued |
0.7985 | Intermediate Similarity | NPD3061 | Approved |
0.7985 | Intermediate Similarity | NPD3062 | Approved |
0.7985 | Intermediate Similarity | NPD3059 | Approved |
0.797 | Intermediate Similarity | NPD597 | Approved |
0.797 | Intermediate Similarity | NPD598 | Approved |
0.797 | Intermediate Similarity | NPD601 | Approved |
0.7955 | Intermediate Similarity | NPD3595 | Approved |
0.7955 | Intermediate Similarity | NPD3594 | Approved |
0.7934 | Intermediate Similarity | NPD1792 | Phase 2 |
0.7923 | Intermediate Similarity | NPD7258 | Clinical (unspecified phase) |
0.791 | Intermediate Similarity | NPD1136 | Approved |
0.791 | Intermediate Similarity | NPD1132 | Approved |
0.791 | Intermediate Similarity | NPD1130 | Approved |
0.7869 | Intermediate Similarity | NPD4254 | Approved |
0.7869 | Intermediate Similarity | NPD4253 | Approved |
0.7868 | Intermediate Similarity | NPD5314 | Approved |
0.7846 | Intermediate Similarity | NPD6583 | Phase 3 |
0.7846 | Intermediate Similarity | NPD6582 | Phase 2 |
0.7836 | Intermediate Similarity | NPD3056 | Clinical (unspecified phase) |
0.7833 | Intermediate Similarity | NPD1444 | Approved |
0.7833 | Intermediate Similarity | NPD1445 | Approved |
0.7817 | Intermediate Similarity | NPD7213 | Phase 3 |
0.7817 | Intermediate Similarity | NPD7212 | Phase 2 |
0.7812 | Intermediate Similarity | NPD2668 | Approved |
0.7812 | Intermediate Similarity | NPD2667 | Approved |
0.7803 | Intermediate Similarity | NPD602 | Approved |
0.7803 | Intermediate Similarity | NPD599 | Approved |
0.7795 | Intermediate Similarity | NPD316 | Approved |
0.7795 | Intermediate Similarity | NPD2226 | Clinical (unspecified phase) |
0.7778 | Intermediate Similarity | NPD829 | Discontinued |
0.7752 | Intermediate Similarity | NPD3421 | Phase 3 |
0.7731 | Intermediate Similarity | NPD4656 | Approved |
0.7731 | Intermediate Similarity | NPD4658 | Approved |
0.7731 | Intermediate Similarity | NPD4229 | Approved |
0.7731 | Intermediate Similarity | NPD4231 | Approved |
0.7727 | Intermediate Similarity | NPD3053 | Approved |
0.7727 | Intermediate Similarity | NPD3055 | Approved |
0.7717 | Intermediate Similarity | NPD9613 | Approved |
0.7717 | Intermediate Similarity | NPD9615 | Approved |
0.7717 | Intermediate Similarity | NPD9616 | Approved |
0.7703 | Intermediate Similarity | NPD6818 | Clinical (unspecified phase) |
0.7692 | Intermediate Similarity | NPD3974 | Phase 2 |
0.7676 | Intermediate Similarity | NPD5241 | Discontinued |
0.7674 | Intermediate Similarity | NPD5723 | Approved |
0.7674 | Intermediate Similarity | NPD1751 | Approved |
0.7674 | Intermediate Similarity | NPD7725 | Approved |
0.7672 | Intermediate Similarity | NPD2860 | Approved |
0.7672 | Intermediate Similarity | NPD2859 | Approved |
0.7669 | Intermediate Similarity | NPD9621 | Approved |
0.7669 | Intermediate Similarity | NPD858 | Approved |
0.7669 | Intermediate Similarity | NPD6584 | Phase 3 |
0.7669 | Intermediate Similarity | NPD859 | Approved |
0.7669 | Intermediate Similarity | NPD9620 | Approved |
0.7669 | Intermediate Similarity | NPD9619 | Approved |
0.7667 | Intermediate Similarity | NPD9610 | Approved |
0.7667 | Intermediate Similarity | NPD9608 | Approved |
0.766 | Intermediate Similarity | NPD3638 | Discontinued |
0.766 | Intermediate Similarity | NPD3060 | Approved |
0.7639 | Intermediate Similarity | NPD7447 | Phase 1 |
0.7639 | Intermediate Similarity | NPD3536 | Discontinued |
0.7627 | Intermediate Similarity | NPD3020 | Approved |
0.7619 | Intermediate Similarity | NPD9614 | Approved |
0.7619 | Intermediate Similarity | NPD9618 | Approved |
0.7591 | Intermediate Similarity | NPD6346 | Approved |
0.7591 | Intermediate Similarity | NPD2238 | Phase 2 |
0.7586 | Intermediate Similarity | NPD2934 | Approved |
0.7586 | Intermediate Similarity | NPD2933 | Approved |
0.7576 | Intermediate Similarity | NPD5157 | Phase 1 |
0.7576 | Intermediate Similarity | NPD5159 | Phase 2 |
0.7576 | Intermediate Similarity | NPD9622 | Approved |
0.7576 | Intermediate Similarity | NPD5158 | Clinical (unspecified phase) |
0.7554 | Intermediate Similarity | NPD2200 | Suspended |
0.7541 | Intermediate Similarity | NPD811 | Approved |
0.7541 | Intermediate Similarity | NPD812 | Approved |
0.7541 | Intermediate Similarity | NPD3526 | Approved |
0.7541 | Intermediate Similarity | NPD810 | Approved |
0.7541 | Intermediate Similarity | NPD3524 | Approved |
0.7537 | Intermediate Similarity | NPD7451 | Discontinued |
0.7535 | Intermediate Similarity | NPD5177 | Phase 3 |
0.7535 | Intermediate Similarity | NPD4236 | Phase 3 |
0.7535 | Intermediate Similarity | NPD4237 | Approved |
0.7521 | Intermediate Similarity | NPD309 | Approved |
0.7521 | Intermediate Similarity | NPD310 | Approved |
0.7521 | Intermediate Similarity | NPD10 | Approved |
0.7521 | Intermediate Similarity | NPD314 | Approved |
0.7521 | Intermediate Similarity | NPD315 | Approved |
0.7521 | Intermediate Similarity | NPD311 | Approved |
0.752 | Intermediate Similarity | NPD4571 | Approved |
0.752 | Intermediate Similarity | NPD4573 | Approved |
0.752 | Intermediate Similarity | NPD4572 | Approved |
0.7519 | Intermediate Similarity | NPD2227 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD6666 | Approved |
0.75 | Intermediate Similarity | NPD6667 | Approved |
0.75 | Intermediate Similarity | NPD4719 | Phase 2 |
0.75 | Intermediate Similarity | NPD4818 | Approved |
0.75 | Intermediate Similarity | NPD3596 | Phase 2 |
0.75 | Intermediate Similarity | NPD4817 | Approved |
0.748 | Intermediate Similarity | NPD1793 | Approved |
0.748 | Intermediate Similarity | NPD1791 | Approved |
0.7463 | Intermediate Similarity | NPD4098 | Discontinued |
0.7462 | Intermediate Similarity | NPD1710 | Approved |
0.7438 | Intermediate Similarity | NPD3683 | Approved |
0.7438 | Intermediate Similarity | NPD3681 | Approved |
0.7431 | Intermediate Similarity | NPD8131 | Suspended |
0.7405 | Intermediate Similarity | NPD9384 | Approved |
0.7405 | Intermediate Similarity | NPD9381 | Approved |
0.74 | Intermediate Similarity | NPD4227 | Discontinued |
0.7394 | Intermediate Similarity | NPD7030 | Discontinued |
0.7388 | Intermediate Similarity | NPD5310 | Approved |
0.7388 | Intermediate Similarity | NPD5311 | Approved |
0.7385 | Intermediate Similarity | NPD6580 | Approved |
0.7385 | Intermediate Similarity | NPD6581 | Approved |
0.7372 | Intermediate Similarity | NPD3136 | Phase 2 |
0.7368 | Intermediate Similarity | NPD2230 | Approved |
0.7368 | Intermediate Similarity | NPD2232 | Approved |
0.7368 | Intermediate Similarity | NPD2233 | Approved |
0.7361 | Intermediate Similarity | NPD3400 | Discontinued |
0.7357 | Intermediate Similarity | NPD4579 | Clinical (unspecified phase) |
0.7343 | Intermediate Similarity | NPD7037 | Approved |
0.7343 | Intermediate Similarity | NPD4256 | Phase 2 |
0.7343 | Intermediate Similarity | NPD4257 | Approved |
0.7338 | Intermediate Similarity | NPD3110 | Approved |
0.7338 | Intermediate Similarity | NPD3109 | Approved |
0.7329 | Intermediate Similarity | NPD2421 | Approved |
0.7329 | Intermediate Similarity | NPD2420 | Approved |
0.7328 | Intermediate Similarity | NPD6830 | Clinical (unspecified phase) |
0.7328 | Intermediate Similarity | NPD6382 | Discontinued |
0.7319 | Intermediate Similarity | NPD2028 | Clinical (unspecified phase) |
0.7313 | Intermediate Similarity | NPD1755 | Approved |
0.7313 | Intermediate Similarity | NPD6025 | Phase 1 |
0.731 | Intermediate Similarity | NPD7910 | Clinical (unspecified phase) |
0.7308 | Intermediate Similarity | NPD7522 | Discontinued |
0.7299 | Intermediate Similarity | NPD5202 | Clinical (unspecified phase) |
0.7295 | Intermediate Similarity | NPD3680 | Approved |
0.7295 | Intermediate Similarity | NPD3682 | Approved |
0.7279 | Intermediate Similarity | NPD7018 | Phase 2 |
0.7279 | Intermediate Similarity | NPD1754 | Clinical (unspecified phase) |
0.7279 | Intermediate Similarity | NPD3645 | Discontinued |
0.7273 | Intermediate Similarity | NPD2029 | Clinical (unspecified phase) |
0.7273 | Intermediate Similarity | NPD6809 | Clinical (unspecified phase) |
0.7273 | Intermediate Similarity | NPD5865 | Clinical (unspecified phase) |
0.7266 | Intermediate Similarity | NPD5745 | Approved |
0.726 | Intermediate Similarity | NPD2422 | Clinical (unspecified phase) |
0.725 | Intermediate Similarity | NPD9609 | Approved |
0.725 | Intermediate Similarity | NPD9612 | Approved |
0.725 | Intermediate Similarity | NPD9611 | Approved |
0.7246 | Intermediate Similarity | NPD3180 | Approved |
0.7246 | Intermediate Similarity | NPD3165 | Approved |
0.7246 | Intermediate Similarity | NPD3179 | Approved |
PubChem CID   | 3689 |
ChEMBL   | CHEMBL305187 |
ZINC   |
Molecular Weight:   | 325.20 |
ALogP:   | -1.4946 |
MLogP:   | 3.44 |
XLogP:   | 6.011 |
# Rotatable Bonds:   | 8 |
Polar Surface Area:   | 43.7 |
# H-Bond Aceptor:   | 2 |
# H-Bond Donor:   | 2 |
# Rings:   | 3 |
# Heavy Atoms:   | 24 |